HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

POLYVINYL ACETATE IS SAFE AS USED, CIR DECLARES

This article was originally published in The Rose Sheet

Executive Summary

POLYVINYL ACETATE IS SAFE AS USED, CIR DECLARES in its revised final report issued at the Cosmetic Ingredient Review (CIR) expert panel's Sept. 12-13 meeting in Washington, D.C. A prior final report on the ingredient published in 1992 stated that the panel had insufficient data to make a determination of the safety of polyvinyl acetate. Since 1992, the panel received requested data, such as the ingredient's composition and information on human skin sensitization and irritation, enabling it to deem the ingredient safe as used in cosmetic products.

You may also be interested in...



Dibutyl Adipate Tentative Amended Safety Assessment Issued By CIR

The Cosmetic Ingredient Review Expert Panel has agreed to issue a tentative amended safety designation for dibutyl adipate after new data were submitted to the panel by industry. The review group made its decision at a meeting in Washington, D.C. Nov. 18-19

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000876

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel